FERRARI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 8.974
EU - Europa 5.661
AS - Asia 784
SA - Sud America 30
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 6
Totale 15.486
Nazione #
US - Stati Uniti d'America 8.954
GB - Regno Unito 1.722
IT - Italia 1.584
DE - Germania 727
SE - Svezia 530
CN - Cina 378
FR - Francia 299
UA - Ucraina 231
PL - Polonia 155
TR - Turchia 145
FI - Finlandia 139
HK - Hong Kong 122
BG - Bulgaria 90
IN - India 51
BE - Belgio 37
RU - Federazione Russa 36
CH - Svizzera 27
BR - Brasile 24
IE - Irlanda 21
NL - Olanda 19
VN - Vietnam 17
CA - Canada 16
SG - Singapore 16
JP - Giappone 14
ZA - Sudafrica 13
KR - Corea 12
IR - Iran 11
ES - Italia 10
MY - Malesia 8
PT - Portogallo 8
EU - Europa 7
DK - Danimarca 6
AT - Austria 4
CL - Cile 4
PK - Pakistan 4
AU - Australia 3
GR - Grecia 3
MX - Messico 3
NZ - Nuova Zelanda 3
RO - Romania 3
TZ - Tanzania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
HU - Ungheria 2
ID - Indonesia 2
MA - Marocco 2
MD - Moldavia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GL - Groenlandia 1
LT - Lituania 1
NG - Nigeria 1
PH - Filippine 1
RS - Serbia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 15.486
Città #
Southend 1.466
Fairfield 1.292
Woodbridge 888
Chandler 753
Ashburn 739
Houston 588
Seattle 518
Ann Arbor 512
Jacksonville 465
Dearborn 458
Cambridge 454
Wilmington 440
Nyköping 363
Frankfurt am Main 352
Modena 255
Kraków 145
Beijing 139
Hong Kong 120
New York 108
Princeton 98
Izmir 90
Sofia 90
San Diego 89
Eugene 87
Fremont 76
Redwood City 67
Helsinki 65
Milan 63
Shanghai 55
Bremen 46
Bologna 37
Rome 36
Des Moines 35
Brussels 32
Grafing 30
London 30
Boardman 29
Falls Church 28
Verona 28
Naples 25
Norwalk 22
Parma 22
Dublin 21
Dong Ket 16
Hefei 16
Paris 16
San Gimignano 14
Nanjing 13
Cape Town 12
Florence 12
Guangzhou 12
Kunming 12
Saint Petersburg 12
Segrate 12
Milwaukee 11
Pavia 11
Ferrara 10
Leawood 10
Napoli 10
Padova 10
Phoenix 10
Prato 10
Salerno 10
Basel 9
Jinan 9
Perugia 9
Torino 9
Trieste 9
Amsterdam 8
Auburn Hills 8
Avellino 8
Kilburn 8
Reggio Emilia 8
San Mateo 8
Palermo 7
Turin 7
Dongguan 6
Draveil 6
Misterbianco 6
Mountain View 6
Nanchang 6
Negrar 6
Ottawa 6
Siena 6
Udine 6
Venice 6
Albinea 5
Aprilia 5
Bari 5
Chengdu 5
Chiswick 5
Hebei 5
Hounslow 5
San Francisco 5
Trento 5
Tulare 5
Warsaw 5
Washington 5
Ancona 4
Athens 4
Totale 11.730
Nome #
STRUTTURA DEL CRISTALLO DEL COMPLESSO DI TIMIDILATO SINTETASI (TS) CON UN LIGANDO 545
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 322
Metodo per la funzionalizzazione sito specifica di molecole proteiche 316
Internalization and stability of a thymidylate synthase peptide inhibitor in ovarian cancer cells 291
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase 290
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 274
USO DI INIBITORI DELLA PTERIDINA REDUTTASI PER LA PREVENZIONE E/O IL TRATTAMENTO DI INFEZIONI PARASSITARIE 264
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections 259
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance 252
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 240
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs 235
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment 230
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 229
Current and Future Chemotherapy for Chagas Disease 229
Antibacterial agent discovery using thymidylate synthase biolibrary screening 226
2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes 221
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 221
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 219
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections 213
Constrained dansyl derivatives reveal bacterial specificity of highly conserved Thymidylate Synthases A 212
Crystal Structure of histidine-tagged human thymidylate synthase 212
NUOVE MOLECOLE, PER USO COME AGENTI ANTITUMORALI 208
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds 208
2′-Deoxyuridine 5′-Monophosphate Substrate Displacement in Thymidylate Synthase through 6-Hydroxy-2H-naphtho[1,8-bc]furan-2-one Derivatives 205
Crystal Structure of human thymidylate synthase bound to a peptide inhibitor 201
Thymidylate synthase structure, function and implication in drug discovery 200
Hotspots in an obligate homodimeric anticancer target. structural and functional effects of interfacial mutations in human thymidylate synthase 200
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors 199
Structure-Based Selectivity Optimization of Piperidine–Pteridine Derivatives as Potent Leishmania Pteridine Reductase Inhibitors 197
Ligand-based discovery of N-(1,3-dioxo-1H,3H-benzo[de]isochromen-5-yl)-carboxamide and sulfonamide derivatives as thymidylate synthase A inhibitors 195
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To InhibitTrypanosoma bruceiPteridine Reductase in Support of Early-Stage Drug Discovery 195
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 194
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells 193
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescenceresonance energy transfer. 192
“A step further in the discovery of phthalein derivatives as Thymidylate Synthase inhibitors” 192
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding. 191
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent 190
Maxwell A: F1000Prime Recommendation of Evaluation [Neres J et al., ACS Chem Biol 2014]. In F1000Prime, 09 Jan 2015; DOI: 10.3410/f.725248139.793502885. F1000Prime.com/725248139#eval793502885 189
Update on antifolate drugs targets 180
Homodimeric Enzymes as Drug Targets 179
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 179
Biochemical effects of riluzole on Leishmania parasites 178
Protein-protein interaction inhibitors: case studies on Small Molecules and Natural Compounds. 175
Inhibitor of Ovarian Cancer Cells growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 173
Biochemistry: Anchors away 173
Improving specificity vs bacterial thymidylate synthases through N-dansyl modulation of didansyltyrosine 171
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development 171
Allosteric Inhibition of human Thymidylate Synthase. 168
QUINOXALINE DERIVATIVES AS ANTITUBERCULOSIS AGENTS 164
ANTICANCER DRUGS 164
Target-based approaches for the discovery of new antimycobacterial drugs 162
A proteomic approach to investigate the mechanism of action of anticancer peptides 161
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case 157
The structure of Cryptococcus neoformans thymidylate synthase suggests strategies for using target dynamics for species-specific inhibition 157
Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: evaluation of in vitro anti-cancer and anti-folate activities 155
Targeting the trypanosomatidic enzymes pteridine reductase and dihydrofolate reductase. 153
Development of flavonoids derivatives as leads against Leishmaniasis and Trypanosomiasis-invited lecture 153
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 150
Alternative strategies in medicinal chemistry to face drug resistance in anticancer therapy. 147
Zing meeting on Medicinal Chemistry 2012-Lanzarote-invitated lecture 147
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 146
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 143
Identification of the binding modes of N-phenylphthalimides inhibiting bacterial thymidylate synthase through X-ray crystallography screening. 143
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 142
Unusual Targeting of the human Thymidylate synthase interface: a tethering approach with mass-spectrometric detection. 140
Intrinsic Fluorescence of the Active and the Inactive Functional Forms of Human Thymidylate Synthase 140
Hits and Lead Discovery in the Identification of New Drugs against the Trypanosomatidic Infections 133
Inhibitor Specificity via Protein Dynamics. Insights from the Design of Antibacterial Agents Targeted Against Thymidylate Synthase 129
COMPOSTI AD ATTIVITÀ ANTIPARASSITARIA 129
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 127
Dal Ligand based design di inibitori della Timidilato Sintasi all'Analisi Comparativa dei Complessi Enzima-Inibitore 126
Anti-Parasitic drugsDiscovery of potent pteridine reductase inhibitors to guide antiparasite drug development. 124
The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism 121
Interfering with Human Thymidylate Synthase Dimerization against ovarian human carcinoma 121
Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase 120
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 117
Novel 3-benzoyl-2-piperazinylquinoxaline derivatives as potential antitumor agents 116
Ovarian Cancer Drug Resistance 116
Congress on - Medicinal Chemistry in parasitology: new avenues in drug discovery-organised in Modena in 2007. 113
Compounds having antiparasitic activity 113
Interfering with Human Thymidylate Synthase Dimerization anti peptide design in the search of anticancer agents against ovarian human carcinoma 112
Rapid-Throughput Technologies Applied to the Discovery of New Hits against Thymidylate synthase Enzymes 99
International Congress.Drug resistance in ovarian cancer:bomarkers andtreatments. 90
From ligand-based design to Hit validation of new thymidylate synthase inhibitors 85
Medicinal chemistry in parasitology 82
Sequence-based Identification of Specific Target Domains in the Thymidylate Synthase Enzyme Family. 79
Laboratory of reference for trypanosomatidic infections -In-Vitro-and-In-Vivo-Screenings-of-New-Antiparasitic-Compounds-State-of-the-art-and-New-Developments-COST B22 71
European COST B22 Lab for antiparasitic drug screening (http://www.icp.ucl.ac.be/cost/costB22/ screening_survey.pdf )-2008-2012. 67
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 55
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents 6
Totale 15.771
Categoria #
all - tutte 49.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.143


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019979 0 0 0 0 0 0 0 0 0 205 467 307
2019/20203.343 252 106 107 210 392 486 577 362 330 131 208 182
2020/20213.068 290 135 212 312 323 196 237 314 156 530 240 123
2021/20222.086 92 189 184 103 81 213 98 140 227 134 404 221
2022/20232.254 243 282 162 226 220 309 52 212 236 50 134 128
2023/20241.517 54 92 114 128 608 184 95 153 69 20 0 0
Totale 15.771